Ricky K Hsu

Weight gain before and after switch from TDF to TAF in a U.S. cohort study

Patrick Mallon, Laurence Brunet, Ricky K Hsu et al. · Journal of the International AIDS Society · 2021 · 128 citations · Full text

Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort

Michael Sension, Laurence Brunet, Ricky K Hsu et al. · Infectious Diseases and Therapy · 2023 · 44 citations · Full text

Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes

Ricky K Hsu, Jennifer S Fusco, Cassidy Henegar et al. · BMC Infectious Diseases · 2023 · 21 citations · Full text

1028. Real-World Use of Long-Acting Cabotegravir + Rilpivirine in People with HIV with Detectable Viral Loads at Initiation: Findings from the OPERA® Cohort

Ricky K Hsu, Michael Sension, Jennifer S Fusco et al. · Open Forum Infectious Diseases · 2023 · 19 citations · Full text

Pharmacotherapy, Antiviral Drug, Harm Reduction +21

Modulation of K65R Selection by Zidovudine Inclusion: Analysis of HIV Resistance Selection in Subjects with Virologic Failure Receiving Once-Daily Abacavir/Lamivudine/Zidovudine and Tenofovir DF (Study COL40263)

Lisa Ross, Richard Elion, Randall Lanier et al. · AIDS Research and Human Retroviruses · 2009 · 10 citations

Zidovudine Susceptibility, Hiv Resistance Selection, Zidovudine Inclusion +14